Concepts (41)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Serpins | 2 | 2018 | 3 | 1.050 |
Why?
|
| Nerve Growth Factors | 2 | 2018 | 5 | 1.050 |
Why?
|
| Neoplasms | 3 | 2024 | 99 | 1.050 |
Why?
|
| Eye Proteins | 2 | 2018 | 36 | 1.010 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 72 | 0.950 |
Why?
|
| Antigens, Neoplasm | 1 | 2024 | 9 | 0.890 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2024 | 34 | 0.890 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2024 | 21 | 0.880 |
Why?
|
| Organoplatinum Compounds | 2 | 2018 | 5 | 0.680 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2018 | 5 | 0.560 |
Why?
|
| Liposomes | 1 | 2018 | 25 | 0.540 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2016 | 2 | 0.490 |
Why?
|
| Oncolytic Virotherapy | 1 | 2015 | 2 | 0.480 |
Why?
|
| Oncolytic Viruses | 1 | 2015 | 2 | 0.480 |
Why?
|
| Simplexvirus | 1 | 2015 | 5 | 0.480 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 28 | 0.340 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 175 | 0.340 |
Why?
|
| Animals | 3 | 2024 | 1817 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2024 | 3 | 0.220 |
Why?
|
| Antibodies, Monoclonal | 1 | 2024 | 19 | 0.220 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 33 | 0.220 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 48 | 0.210 |
Why?
|
| Membrane Proteins | 1 | 2024 | 49 | 0.210 |
Why?
|
| Humans | 4 | 2024 | 5477 | 0.210 |
Why?
|
| Female | 2 | 2024 | 2811 | 0.190 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2021 | 6 | 0.180 |
Why?
|
| Virus Internalization | 1 | 2021 | 7 | 0.180 |
Why?
|
| Peptoids | 1 | 2021 | 5 | 0.180 |
Why?
|
| Mice | 1 | 2024 | 719 | 0.180 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 14 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 22 | 0.140 |
Why?
|
| Up-Regulation | 1 | 2018 | 30 | 0.140 |
Why?
|
| Cell Proliferation | 1 | 2018 | 120 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 14 | 0.120 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2015 | 2 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 55 | 0.120 |
Why?
|
| Cell Differentiation | 1 | 2016 | 75 | 0.120 |
Why?
|
| Signal Transduction | 1 | 2016 | 225 | 0.100 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 11 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2021 | 17 | 0.040 |
Why?
|
| Protein Binding | 1 | 2021 | 118 | 0.040 |
Why?
|